Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Dept. of Justice Outlines Option to Settle Camp Lejeune Lawsuits More Quickly The court was provided details about a Camp Lejeune settlement “Elective Option”, which lists the types of injuries and times of exposure which will govern how much claimants may be compensated for due to water contamination September 12, 2023 Irvin Jackson Add Your Comments The U.S. government has filed a notice to inform judges presiding over all Camp Lejeune water contamination lawsuits of a new “Elective Option”, detailing the voluntary process that will allow individuals to quickly settle claims involving certain injuries linked to toxic chemicals that contaminated water at the North Carolina military base. The Department of Justice and U.S. Navy first announced the elective Camp Lejeune settlement option on September 7, offering up to $550,000 to veterans and their families if they suffered specific medical conditions, including kidney cancer, liver cancer, non-Hodgkins lymphoma, leukemias, bladder cancer, multiple myeloma, Parkinson’s disease, kidney disease and systemic sclerosis. The government hopes the option to settle Camp Lejeune lawsuits quickly will help resolve a large portion of the nearly 100,000 claims that have already been presented under a new law that went into effect last year. The Camp Lejeune Justice Act (CJLA) of 2022 opened a two-year window for lawsuits to be filed by individuals injured by contaminated water on the base between the mid-1950s and late-1980s. However, the size and scope of the litigation is expected to continue to increase over the coming year, and it is widely expected that the litigation will become the largest mass tort in U.S. history by the time the filing window closes in August 2024. The sprawling litigation involves dozens of different injuries allegedly caused by chemicals known to have contaminated water at Camp Lejeune, including various types of cancer, Parkinson’s disease, birth defects and other injuries, each of which plaintiffs must establish was at least as likely as not to have been caused by exposure to water on the base. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Over the past year, the Navy and DOJ have faced sharp criticism over failing to settle Camp Lejeune claims promptly, following reports that indicated no agreements had been reached, even though the law required each claimant to wait 180 days after submitting notice of their claim before filing a lawsuit. The administrative period was intended to allow the U.S. government time to resolve claims, but there has been no visible effort to achieve those goals. The federal government provided a notice (PDF) to the Court on September 7, formerly notifying the judges in the U.S. District Court for the Eastern District of North Carolina about the elective option and providing details about the settlement opportunity. Camp Lejeune Settlement Offer Details The Camp Lejeune Elective Option will provide settlements ranging from about $100,000 to $550,000, for individuals who suffered specific types of cancer and diseases that have been identified as potentially linked to Camp Lejeune drinking water contamination by the Agency for Toxic Substances and Disease Registry. Those who take the Elective Option being offered by the government would be divided into two tiers of qualifying injuries. Tier 1 includes those injuries backed by evidence of a causal link between one or more contaminants found at Camp Lejeune, including: Kidney Cancer Liver Cancer Non-Hodgkin’s Lymphoma Leukemias Bladder Cancer Tier 2 includes injuries where there is enough research to support a link between a contaminant and the injury, but not enough to firmly conclude there is a causal link, including: Multiple Myeloma Parkinson’s Disease Kidney Disease/End Stage Renal Disease Systemic Sclerosis/Systemic Scleroderma The two tiers will be further divided into categories based on how long they were exposed to water at the military base, with claimants receiving a larger reward based on how long they were exposed to water at the base, and which tier of injury they experienced. Tier 1 Qualifying Injuries will receive $150,000 if they lived or worked on the base between 30 days and a year, $300,000 for one to five years of exposure, and $450,000 if they lived or worked at Camp Lejeune for longer than five years. Tier 2 Qualifying injuries will get $100,000 for a month to a year of exposure, $250,000 for one to five years, and $400,000 for more than five years. Camp Lejeune Elective Option Requirements In addition to the qualifications applied to all Camp Lejeune lawsuit plaintiffs, those who wish to participate in the elective option must properly present an administrative claim to the Department of the Navy. Their injury must have been first diagnosed or treated before August 10, 2022. To qualify for the Elective Option, the claimant’s diagnosis must have occurred at least two years after their first exposure to Camp Lejeune water, and no longer than 35 years after they were last exposed. They must also have the appropriate medical documentation showing their diagnosis or treatment, and there must be evidence that they resided or were employed at Camp Lejeune for at least 30 days between August 1, 1953 and December 31, 1987. Plaintiffs Who Don’t Qualify for Elective Option May Still File Claims The Department of Justice notes that claimants who do not qualify because they have not suffered those specific injuries, or for other reasons, may still file a claim and seek relief from the U.S. Navy. The government noted that there may be additional Camp Lejeune settlement frameworks introduced in the future, as the officials continues to look at the scientific evidence, and as the litigation develops. The Elective Option was proposed just days after parties in the litigation submitted competing Camp Lejeune trial and discovery plans to begin preparing the first bellwether test cases for trial. While the outcome of the early Camp Lejeune bellwether trials would not have a binding impact on other claims, the amount of any lawsuit payouts awarded may help the parties determine how juries will respond in future cases and facilitate settlement negotiations for different categories of injuries. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Camp Lejeune, Cancer, Military, North Carolina, Veterans, Veterans Affairs, Water Contamination Image Credit: | More Camp Lejeune Lawsuit Stories Trichloroethylene Exposure Linked to Parkinson’s Disease Risk: Study October 8, 2025 Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025 U.S. Government Seeks Dismissal of Camp Lejeune Kidney Cancer Lawsuits September 15, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: today) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025) Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025
Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: today) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)